Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. Its FXR product candidates include MET409 and MET642.
If you want more trading ideas like this one ,đŻ press a thumb up! đ Have a question? Don't be shy to ask! đ€ Interested to study how to analyze charts, follow me!
If you want more trading ideas like this one ,đŻ press a thumb up! đ Have a question? Don't be shy to ask! đ€ Interested to study how to analyze charts, follow me!